Healthy Day for Blackmores on Kirin Overture
Shares in health supplements company Blackmores surged 22% on Thursday after a $1.9 billion bid at $95 per share by Japanese brewer Kirin, owner of the Lion beer business.
Read More
Blackmores Limited
Blackmores is Australia’s leading natural health company. Based on the vision of our founder Maurice Blackmore (1906-1977), we are passionate about natural health and inspiring people to take control of and invest in their wellbeing. We develop high quality products and services that deliver a more natural approach to health, based on our expertise in vitamins, minerals, herbs and nutrients.
Videos
Videos coming soon for Blackmores Limited.
News
Health Sector Headlines: RHC, BKL
Polar opposite prognoses from a couple of our healthcare stocks on Thursday, with private hospital operator Ramsay looking rosy but nutritional supplement retailer Blackmores decidedly less so.
Read More
BKL – Credit Suisse rates the stock as Neutral
Neutral rating and $90 target price retained.
Read More
BKL – Citi rates the stock as Sell
The Sell rating and target price of $73.16 are retained.
Read More
Bega, Blackmores Reports All But Lost in the Rush
Bigger issues dominated the investment mindset on Thursday as the market took a big dive, rendering virtually moot the reactions to earnings reports from Bega and Blackmores.
Read More
BKL – Macquarie rates the stock as Neutral
Macquarie raises its target price to $93.50 from $78.50 after Blackmores posted FY21 results. The Neutral rating is unchanged.
Read More
BKL – Credit Suisse rates the stock as Neutral
Gross margin expansion is anticipated moving to the high 50% levels from 52%. Credit Suisse downgrades estimates for earnings per share by -2-4% and retains a Neutral rating.
Read More
BKL – Citi rates the stock as Sell
Despite having better sales momentum than Swisse in A&NZ, competition could increase for Blackmores over 2021 as Swisse plans to invest in marketing and branding and expand its practitioner brand Nutra+, explains Citi. The $59.20 target and the Sell rating are retained.
Read More
BKL – Citi rates the stock as Sell
The broker highlights material cost-outs and success in SE Asian markets as driving Blackmores' result, but retains Sell. Target falls to $59.20 from $50.60.
Read More
Blackmores Eyes Job Cuts As Profit Slides 66%
No final payout for shareholders from vitamins and health supplements company Blackmores which is looking to cut about 10% of its workforce after revealing a forecast slump in net profit for the year to June.
Read More
